Eli Lilly (LLY) is a publicly traded Healthcare sector company. As of May 20, 2026, LLY trades at $1,017.07 with a market cap of $881.12B and a P/E ratio of 43.77. LLY moved -0.53% today. Year to date, LLY is -2.17%; over the trailing twelve months it is +36.39%. Its 52-week range spans $623.78 to $1,133.95. Analyst consensus is strong buy with an average price target of $1,262.85. Rallies surfaces LLY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
LLY financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. LLY recently traded at $1,017.07. Market cap is $881.12B. P/E ratio is 43.77. Revenue is $65.18B.
| Metric | Value |
|---|---|
| Price | $1,017.07 |
| Market Cap | $881.12B |
| P/E Ratio | 43.77 |
| EPS | $23.00 |
| Dividend Yield | 1.73% |
| 52-Week High | $1,133.95 |
| 52-Week Low | $623.78 |
| Volume | 2.02M |
| Avg Volume | 0 |
| Revenue (TTM) | $65.18B |
| Net Income | $20.64B |
| Gross Margin | 83.04% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $65.18B | $20.64B | $23.00 |
| 2024 | $45.04B | $10.59B | $11.76 |
| 2023 | $34.12B | $5.24B | $5.82 |
| 2022 | $28.54B | $6.24B | $6.93 |
22 analysts cover LLY: 0 strong buy, 19 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $1,262.85.